Archive for February 12th, 2009
NEW ROGUES
FROM CONSUMERAFFAIRS.COM
~Sandy G.
February 12, 2009
RECALLS
Jetboil Recalls Outdoor Stoves
FOR COMPLETE STORY, PLEASE CLICK HERE.
Marzocchi Recalls Bicycle Forks
FOR COMPLETE STORY, PLEASE CLICK HERE.
~Sandy G.
February 12, 2009
PCA SHUTS SECOND PEANUT PLANT IN SALMONELLA SCARE
Texas plant closed after tests find possible contamination
FROM CONSUMERAFFAIRS.COM
Peanut Corporation of America, the company at the heart of the spreading salmonella outbreak linked to peanut butter, has closed a second plant, this one in Texas.
The Texas Department of State Health Services asked the company to close the Plainview, Texas plant after laboratory tests of sample products from the plant indicated the possible presence of Salmonella in some products. PCA discovered the problem and notified the Texas Department of State Health Services of the findings on Monday, the agency said.
DSHS officials said it does not appear that any of the implicated products – peanut meal, granulated peanuts and dry roasted peanuts – have reached consumers. The testing was done by a private lab under contract with PCA.
FOR COMPLETE STORY, PLEASE CLICK HERE.
~Sandy G.
February 12, 2009
BONE DRUGS MAY HELP FIGHT BREAST CANCER
By GINA KOLATA
A drug of a class commonly used to combat bone loss may reduce by a third the chance that some breast cancers will spread or recur, a large study has found.
While it may sound odd to treat cancer with a drug that acts on bone, evidence is accumulating that such drugs may do more than just prevent the loss of bone. Other studies are testing the drugs in patients with prostate or lung cancer.
The new study, published in Thursday’s New England Journal of Medicine, involved 1,803 premenopausal women with tumors that were fueled by estrogen. As part of their treatment, all received drugs that shut down their ovaries, preventing them from making estrogen, along with drugs that stymie cancer cells from using estrogen to grow.
Half also got the bone drug zoledronic acid, or Zometa, as an intravenous infusion twice a year for three years. Those who took the drug had a 36 percent reduction in cancer recurrences and metastases, compared with women who did not get it. After nearly four years, 54 women who received zoledronic acid and 83 who did not had a recurrence of their cancer or had a new cancer in the opposite breast or a metastasis to their bones.
FOR COMPLETE STORY, PLEASE CLICK HERE.
~Sandy G.
February 12, 2009
